IMPDH1 is a potential immune evasion-related oncoprotein in endometrial cancer

Yongning Chen, Fei Ma, Weichang Chen, Ruibin Jiang, Fei Wu, Shipeng Gong, Yadi Zhang · 2026

Read IMPDH1 is a potential immune evasion-related oncoprotein in endometrial cancer by Yongning Chen, Fei Ma, Weichang Chen, Ruibin Jiang, Fei Wu, Shipeng Gong, Yadi Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13276951.txt.

Description

Yongning Chen and co-authors identify a metabolic enzyme as a marker of immune evasion in womb cancer. Their 2026 study starts from tumor and nearby normal tissue taken from patients. Protein profiling, gene data, survival analysis, and immune cell estimates were combined to find molecules tied to how the cancer interacts with immunity.

One protein stood out as strongly raised in tumors and linked to worse outcomes. High levels of it went with fewer killer T cells inside the tumor and other signs of a suppressed immune setting. Pathway analysis tied it to purine metabolism. The authors propose the protein as a candidate target and prognostic marker. Immune therapies need such footholds in a cancer where proven immune biomarkers are scarce.

Catalog record

CREATORYongning Chen, Fei Ma, Weichang Chen, Ruibin Jiang, Fei Wu, Shipeng Gong, Yadi Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13276951

Browse the full library · About the Tower of Babel